119 related articles for article (PubMed ID: 37976368)
1. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
Li H; Tang X; Sun Z; Qu Z; Zou X
Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
[TBL] [Abstract][Full Text] [Related]
2. Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells.
Qu Z; Zou X; Zhang X; Sheng J; Wang Y; Wang J; Wang C; Ji Y
Mol Med Rep; 2016 Feb; 13(2):1336-44. PubMed ID: 26677104
[TBL] [Abstract][Full Text] [Related]
3. Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT signalling pathways.
Paul A; Bishayee K; Ghosh S; Mukherjee A; Sikdar S; Chakraborty D; Boujedaini N; Khuda-Bukhsh AR
Zhong Xi Yi Jie He Xue Bao; 2012 Sep; 10(9):1025-38. PubMed ID: 22979935
[TBL] [Abstract][Full Text] [Related]
4. Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling.
Pham TH; Page YL; Percevault F; Ferrière F; Flouriot G; Pakdel F
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466512
[TBL] [Abstract][Full Text] [Related]
5. The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis.
Lallemand F; Vacher S; de Koning L; Petitalot A; Briaux A; Driouch K; Callens C; Schnitzler A; Lecerf C; Oulie-Bard F; Barbet A; Vincent A; Zinn-Justin S; Lopez BS; Lidereau R; Bieche I; Caputo SM
Sci Rep; 2020 Apr; 10(1):6920. PubMed ID: 32332845
[TBL] [Abstract][Full Text] [Related]
6. Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis.
Saavedra-García P; Nichols K; Mahmud Z; Fan LY; Lam EW
Mol Cell Endocrinol; 2018 Feb; 462(Pt B):82-92. PubMed ID: 28087388
[TBL] [Abstract][Full Text] [Related]
7. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.
Khongkow P; Gomes AR; Gong C; Man EP; Tsang JW; Zhao F; Monteiro LJ; Coombes RC; Medema RH; Khoo US; Lam EW
Oncogene; 2016 Feb; 35(8):990-1002. PubMed ID: 25961928
[TBL] [Abstract][Full Text] [Related]
9. MiR-940 promotes malignant progression of breast cancer by regulating FOXO3.
Zhang H; Peng J; Lai J; Liu H; Zhang Z; Li X; Liang B; Chen X; Zou B; Lin S; Zhang L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32840296
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia protein (PML) controls breast cancer cell proliferation by modulating Forkhead transcription factors.
Sachini N; Arampatzi P; Klonizakis A; Nikolaou C; Makatounakis T; Lam EW; Kretsovali A; Papamatheakis J
Mol Oncol; 2019 Jun; 13(6):1369-1387. PubMed ID: 30927552
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer.
Pérez-Peña J; Győrffy B; Amir E; Pandiella A; Ocaña A
Breast Cancer Res Treat; 2018 Dec; 172(3):725-732. PubMed ID: 30206781
[TBL] [Abstract][Full Text] [Related]
12. The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.
Yao S; Fan LY; Lam EW
Semin Cancer Biol; 2018 Jun; 50():77-89. PubMed ID: 29180117
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-FOXO3 axis to modulate cancer drug resistance and clonal survival.
Alasiri G; Jiramongkol Y; Trakansuebkul S; Ke HL; Mahmud Z; Intuyod K; Lam EW
Mol Cell Endocrinol; 2020 Sep; 515():110932. PubMed ID: 32615282
[TBL] [Abstract][Full Text] [Related]
14. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
16. Role of circ-FOXO3 and miR-23a in radiosensitivity of breast cancer.
Abdollahi E; Mozdarani H; Alizadeh BZ
Breast Cancer; 2023 Sep; 30(5):714-726. PubMed ID: 37222952
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer.
Modi A; Purohit P; Roy D; Vishnoi JR; Pareek P; Elhence P; Singh P; Sharma S; Sharma P; Misra S
Mol Biol Rep; 2022 Apr; 49(4):2877-2888. PubMed ID: 35066766
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer.
Hamurcu Z; Sener EF; Taheri S; Nalbantoglu U; Kokcu ND; Tahtasakal R; Cınar V; Guler A; Ozkul Y; Dönmez-Altuntas H; Ozpolat B
Cell Signal; 2021 Jul; 83():109979. PubMed ID: 33744419
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/FOXO3 pathway in ovarian cancer cells.
Bae JS; Lee J; Park Y; Park K; Kim JR; Cho DH; Jang KY; Park SH
Oncol Rep; 2017 Oct; 38(4):2417-2425. PubMed ID: 28765909
[TBL] [Abstract][Full Text] [Related]
20. FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells.
Yao H; Li J; Zhou D; Pan X; Chu Y; Yin J
Int J Clin Oncol; 2024 Mar; 29(3):333-344. PubMed ID: 38172354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
